Research ArticleMetabolism

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

See allHide authors and affiliations

Science Translational Medicine  03 Mar 2021:
Vol. 13, Issue 583, eabc8980
DOI: 10.1126/scitranslmed.abc8980

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article